Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Name
Vander heiden_Macropinocytosis.pdf
Size
1.69 MB
Format
Adobe PDF
Checksum (MD5)
05b36d2081fb0c040a0ebc778c550ea1
Author(s)
Commisso, Cosimo
Davidson, Shawn Michael
Soydaner-Azeloglu, Rengin G.
Parker, Seth J.
Kamphorst, Jurre J.
Hackett, Sean
Grabocka, Elda
Nofal, Michel
Drebin, Jeffrey A.
Thompson, Craig B.
Date Issued
May 2013
Journal
Nature
Publisher
Nature Publishing Group
Citation
Commisso, Cosimo, Shawn M. Davidson, Rengin G. Soydaner-Azeloglu, Seth J. Parker, Jurre J. Kamphorst, Sean Hackett, Elda Grabocka, Michel Nofal, Jeffrey A. Drebin, Craig B. Thompson, Joshua D. Rabinowitz, Christian M. Metallo, Matthew G.Vander Heiden, and Dafna Bar-Sagi. "Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells." Nature 497:7451 (2013), p.633-637.
Version
Author's final manuscript
Abstract
Macropinocytosis is a highly conserved endocytic process by which extracellular fluid and its contents are internalized into cells through large, heterogeneous vesicles known as macropinosomes. Oncogenic Ras proteins have been shown to stimulate macropinocytosis but the functional contribution of this uptake mechanism to the transformed phenotype remains unknown1, 2, 3. Here we show that Ras-transformed cells use macropinocytosis to transport extracellular protein into the cell. The internalized protein undergoes proteolytic degradation, yielding amino acids including glutamine that can enter central carbon metabolism. Accordingly, the dependence of Ras-transformed cells on free extracellular glutamine for growth can be suppressed by the macropinocytic uptake of protein. Consistent with macropinocytosis representing an important route of nutrient uptake in tumours, its pharmacological inhibition compromises the growth of Ras-transformed pancreatic tumour xenografts. These results identify macropinocytosis as a mechanism by which cancer cells support their unique metabolic needs and point to the possible exploitation of this process in the design of anticancer therapies.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1038/nature12138
